Clinical trial Recruiting at 1 site Observational Ages 5 and up

EGR2 and NLRP3 pathways in sleep apnea-related thinking and mood problems

Official title: Regulatory Mechanisms of EGR2 and NLRP3 Inflammatory Pathways in Cognitive Impairment and Depressive-Anxiety-Like Behaviors Associated With Obstructive Sleep Apnea-Hypopnea Syndrome

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT07120711 · Data updated 2026-11-12

This study will test whether activity in the EGR2 and NLRP3 inflammation pathways is linked to thinking, memory, and mood problems in children and adults with obstructive sleep apnea compared with healthy volunteers.

Quick facts

Study typeObservational
Ages5 Years and up
SexAll
Enrollment1000 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJuly 22, 2025
Study endsSeptember 30, 2026
Registry record updatedAugust 13, 2025
Trial IDNCT07120711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–18 with obstructive snoring or sleep apnea features on ENT screening and adults >18 with suspected OSAS (chronic snoring, witnessed apneas, or daytime sleepiness) who are not pregnant and do not have severe organ failure or major neurological disease are ideal candidates.

Probably not a fit

Patients with congenital craniofacial malformations, severe heart, lung, liver, or kidney failure, major neurological disease, current psychiatric disorders, recent use of immunomodulatory drugs, pregnancy, or participation in another clinical trial are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll children (ages 2–18) and adults (>18) with obstructive sleep apnea-hypopnea syndrome (OSAS) alongside age- and sex-matched healthy volunteers. Children will undergo ENT examinations including nasal endoscopy and X-rays, while adults will receive overnight polysomnography; all participants will complete standardized sleepiness, mood, and cognitive questionnaires. Small blood draws will be collected from all participants and tiny adipose tissue samples obtained when available (for example during surgery) to measure EGR2 and NLRP3 pathway activity and inflammatory markers. Molecular data will be correlated with cognitive screening and mood scores to explore mechanisms linking intermittent hypoxia and inflammation to neurobehavioral symptoms in OSAS.

Why it matters

Potential benefit: If successful, the study could identify molecular markers that explain cognitive and mood problems in OSAS and suggest new targets for prevention or treatment.

How similar studies have gone: Prior research has linked intermittent hypoxia and inflammasome activation including NLRP3 to inflammation and cognitive effects in OSA, but direct clinical correlations involving EGR2 and adipose tissue sampling remain relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Children aged 2-18 years with obstructive snoring or sleep apnea features on initial ENT outpatient screening.

Adults (\>18 years) with suspected OSAS in a sleep or respiratory clinic, presenting with chronic snoring, witnessed apneas, or daytime sleepiness, and without severe chronic heart, liver, kidney failure, psychiatric disorders, or pregnancy.

Signed written informed consent by the participant or their legal guardian. Not currently enrolled in any other registered clinical trial.

Exclusion Criteria:

Presence of congenital craniofacial malformations. Severe heart, lung, liver, or kidney failure, or major neurological disease. Recent use of anti-inflammatory or other immunomodulatory medications. Current psychiatric disorder or pregnancy

Where it's running

  • Shanghai Xinhua hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.